Physician profile
Mohammad Nikpourfard
NPI 1407986896
$3,049.54
in general payments reported to CMS, 2019-2025
8 companies · $25.00 in 2025
The $25.00 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $144 · 2021: $726 · 2022: $199 · 2023: $1,817 · 2024: $38.46 · 2025: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,159 · Food and Beverage: $596 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,159.36 |
| Food and Beverage | $596.48 |
| Education | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,470.15 | 2022-2023 | |
| Align Technology, INC. | $511.92 | 2020-2025 | Invisalign |
| Zimmer Biomet Holdings, INC. | $475.00 | 2019-2021 | |
| Straumann USA LLC | $309.95 | 2019-2023 | |
| Dentsply Sirona INC | $135.89 | 2022-2023 | Waveone Gold Conform Fit |
| Orapharma, A Division of Bausch Health US, LLC | $59.24 | 2021-2022 | |
| Philips North America LLC | $57.01 | 2020-2022 | |
| 3m Company | $30.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Nikpourfard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.